Stratification of gastric cancer risk by H. pylori Infection

Helicobacter Pylori

Volumn , Issue , 2016, Pages 169-179

  Inoue, Kazuhiko ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

ABC classification; Endoscopy; Gastric cancer; Helicobacter pylori; Pepsinogen; Radiography; Screening

Indexed keywords

EID: 84978259234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-55705-0_11     Document Type: Chapter

References (34)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet. 1983;321:1273-5.
2. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer. BMJ. 1991;302:1302-5.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med. 1991;325:1127-31.
4. Nomura A, Stemmerman GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132-6.
5. WHO. Schistosomes, liver flukes and Helicobacter pylori: IARC working group on the evaluation of carcinogenic risks to humans, IARC monographs on the evaluation of carcinogenetic risks to humans, IARC scientific publication no. 61, vol. 61. Lyon: IARC; 1994. p. 218-20.
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
7. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2001;16:415-9. doi:10.1111/j.1523-5378.2011.06893.x.
8. Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59-65. doi:10.1159/000339176. Epub 2012 Jun 20.
9. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642-8.
10. Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, et al. High salt diets dosedependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer. 2006;119:1558-66.
11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process; First American cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735-40.
12. Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, et al. Relationship between the degree of the endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91:30-6.
13. Inoue K, Fujisawa T, Chinuki D, Kushiyama Y. Characteristics of gastric mucosa in gastric cancer improvement - examination from a clinical survey by endoscopy. Stomach Intestine. 2009;44:1367-73 (in Japanese with English abstract).
14. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87-96.
15. Kamada T, Hata J, Tanaka A, Kusunoki H, Miyamoto M, Inoue K, et al. Nodular gastritis and gastric cancer. Dig Endosc. 2006;18:79-83. doi:10.1111/j.0915-5635.2006.00588.x.
16. Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Yasunaga Y, et al. Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol. 2003;18:1384-91.
17. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori infection on subsequent development of cancer after endoscopic resection of gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639-42.
18. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early cancer: an open-label, randomized controlled trial. Lancet. 2008;372:392-7. doi:10.1016/S0140-6736(08)61159-9.
19. Yohn SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014;19:243-8. doi:10.1111/hel.12146.
20. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;20:348:g3174. 10.1136/bmj.g3174.
21. Samloff IM. Pepsinogens I, and II; purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology. 1982;82:26-33.
22. Samloff IM, Varis K, Ihamaki KT, Siurala M, Rotter JI. Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204-9.
23. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroentereol Jpn. 1987;22:133-41.
24. Miki K, Ichinose M, Ishikawa K, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res. 1993;84:1086-90.
25. Inoue K. Evaluation of serum pepsinogens and anti-H.pylori antibodies for screening of gastric cancer. Clin Gastroenterol. 2002;17:1591-8 (in Japanese with English abstract).
26. Inoue K, Fujisawa T, Haruma H. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers. 2010;25:207-12.
27. Inoue K, Fujisawa T, Nishi T, et al. Utilities and problems of the ABC classification - including examination of the reference value of pepsinogens. Helicobacter Res. 2011;15:422-7 (in Japanese).
28. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138-43.
29. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764-8.
30. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74-94. doi:10.1055/s-0031-1291491. Epub 2011 Dec 23.
31. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631-6.
32. Ohshima A, Hirata N, Ubukata T, Fujimoto I. Evaluation of a mass screening program for stomach with a case-control study design. Int J Cancer. 1986;38:829-33.
33. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takao A. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan; a population-based case-control study. Int J Cancer. 1995;60:45-8.
34. Abe Y, Mitsushima T, Nagatani Y, Ikuma H, Minamihara Y. Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study. A study of efficient screening programma for stomach cancer. J Gastroenterol. 1995;92:836-45 (in Japanese).